CN104905405B - The cigarette of the essence containing plant flavone mouth stick preparation method and application - Google Patents
The cigarette of the essence containing plant flavone mouth stick preparation method and application Download PDFInfo
- Publication number
- CN104905405B CN104905405B CN201510336905.0A CN201510336905A CN104905405B CN 104905405 B CN104905405 B CN 104905405B CN 201510336905 A CN201510336905 A CN 201510336905A CN 104905405 B CN104905405 B CN 104905405B
- Authority
- CN
- China
- Prior art keywords
- cigarette
- essence
- containing plant
- extract
- tow
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000019504 cigarettes Nutrition 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 5
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 title 1
- 229930003944 flavone Natural products 0.000 title 1
- 150000002212 flavone derivatives Chemical class 0.000 title 1
- 235000011949 flavones Nutrition 0.000 title 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 title 1
- 229930003935 flavonoid Natural products 0.000 claims abstract description 48
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 48
- 235000017173 flavonoids Nutrition 0.000 claims abstract description 48
- 241000196324 Embryophyta Species 0.000 claims abstract description 33
- 239000000284 extract Substances 0.000 claims abstract description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- 241000208125 Nicotiana Species 0.000 claims abstract description 21
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 21
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims abstract description 18
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000000605 extraction Methods 0.000 claims abstract description 12
- 238000010992 reflux Methods 0.000 claims abstract description 11
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 claims abstract description 9
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 9
- 235000008777 kaempferol Nutrition 0.000 claims abstract description 9
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000000465 moulding Methods 0.000 claims abstract description 9
- 229930019673 naringin Natural products 0.000 claims abstract description 9
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 claims abstract description 9
- 229940052490 naringin Drugs 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims description 8
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims description 8
- 229960003321 baicalin Drugs 0.000 claims description 8
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims description 8
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 claims description 8
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 claims description 8
- 235000009498 luteolin Nutrition 0.000 claims description 8
- 239000007921 spray Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims 1
- 239000000779 smoke Substances 0.000 abstract description 18
- 239000000126 substance Substances 0.000 abstract description 12
- 210000000214 mouth Anatomy 0.000 abstract description 11
- 210000000867 larynx Anatomy 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 230000000391 smoking effect Effects 0.000 description 14
- 206010062717 Increased upper airway secretion Diseases 0.000 description 9
- 208000026435 phlegm Diseases 0.000 description 9
- 210000002345 respiratory system Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 6
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000005507 spraying Methods 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000000241 respiratory effect Effects 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 206010016654 Fibrosis Diseases 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 102000012335 Plasminogen Activator Inhibitor 1 Human genes 0.000 description 2
- 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 102000004504 Urokinase Plasminogen Activator Receptors Human genes 0.000 description 2
- 108010042352 Urokinase Plasminogen Activator Receptors Proteins 0.000 description 2
- 210000002821 alveolar epithelial cell Anatomy 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000009816 urokinase plasminogen activator receptor activity proteins Human genes 0.000 description 2
- 108040001269 urokinase plasminogen activator receptor activity proteins Proteins 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000014085 Chronic respiratory disease Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 1
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 description 1
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 description 1
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 1
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000000424 bronchial epithelial cell Anatomy 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012887 cigarette smoke extract Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 231100000516 lung damage Toxicity 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001779 taste bud Anatomy 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/02—Manufacture of tobacco smoke filters
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Cosmetics (AREA)
Abstract
本发明公开一种含植物黄酮香精的烟用嘴棒制备方法及应用,1)按重量百分比称取20%~60%的木犀草素、20%~60%的黄芩苷、10%~30%的山奈酚、10%~30%的柚皮苷,混合后乙醇溶液作为提取溶剂回流提取,过滤得到提取液;2)将提取液均匀喷洒在丝束中;3)然后将步骤2)中的丝束干燥;4)将干燥后的丝束依次用成型纸和嘴棒接装纸包裹,制得含植物黄酮香精的烟用嘴棒。该含植物黄酮香精的烟用嘴棒给烟支带来舒适的嗅香感觉,烟支抽吸时,这些物质经燃烧裂解出能够增加香气量和香气质的致香成分;且植物黄酮香精的烟用嘴棒中活性成分在卷烟中随烟气进入人体口腔,可以直接作用于喉部,起到良好的提高喉部舒适性的作用。The invention discloses a preparation method and application of a tobacco mouth stick containing plant flavonoid essence. kaempferol, 10% to 30% naringin, after mixing, the ethanol solution is used as the extraction solvent for reflux extraction, and the extract is filtered to obtain the extract; 2) the extract is evenly sprayed in the tow; 3) then the extract in step 2) drying the tow; 4) wrapping the dried tow with molding paper and tipping paper in turn to prepare a cigarette tip containing plant flavonoid essence. The cigarette mouthpiece containing plant flavonoid essence brings comfortable smelling feeling to the cigarette. When the cigarette is smoked, these substances are burned and cracked to produce aroma components that can increase the amount and quality of aroma; and the tobacco with plant flavonoid essence The active ingredient in the mouth stick enters the oral cavity of the human body along with the smoke in the cigarette, and can directly act on the larynx to improve the comfort of the larynx.
Description
技术领域technical field
本发明属于卷烟技术领域,具体涉及一种含植物黄酮香精的烟用嘴棒制备方法及应用。The invention belongs to the technical field of cigarettes, and in particular relates to a preparation method and application of a cigarette mouthpiece containing plant flavonoid essence.
背景技术Background technique
天然植物在烟用香料中应用广泛,其中很多是含有黄酮类物质。根据黄酮类物质的分子结构特征和电子间的作用力的强弱,初步研究发现该类物质在燃烧裂解以后会产生呋喃类物质及其衍生物,这些物质是烟气中的主要致香成分,会给烟气带来焦糖香、甜香、烤香,增加香气量和香气质。因此在烟用香精香料的调配中,有很多黄酮类香原料的使用。Natural plants are widely used in tobacco flavors, many of which contain flavonoids. According to the molecular structure characteristics of flavonoids and the strength of the interaction between electrons, preliminary studies have found that such substances will produce furan substances and their derivatives after combustion and cracking. These substances are the main aroma components in smoke. It will bring caramel, sweet and roasted aroma to the smoke, and increase the amount and quality of aroma. Therefore, in the deployment of flavors and fragrances for tobacco, there are many flavonoid flavor raw materials used.
许多研究也表明,黄酮类化合物具有多种生物活性,除利用其抗菌、消炎、抗突变、降压、清热解毒、镇静、利尿等作用外,在抗氧化、抗癌、防癌、抑制脂肪酶等方面也有显著效果。它是大多数氧自由基的清除剂,因而能升高SOD(过氧化物歧化酶)的活力,减少MDA(脂质过氧化物丙二醛)及OX-LDL(氧化低密度脂蛋白)的生成。它可以增加冠脉流量,对实验性心肌梗塞有对抗作用;对急性心肌缺血有保护作用;对治疗冠心病、心绞痛、高血压等有显著效果;对降低舒张压,防治心律失常、心血管病和活血化瘀也起重要作用。Many studies have also shown that flavonoids have a variety of biological activities. In addition to their antibacterial, anti-inflammatory, anti-mutation, blood pressure, heat-clearing and detoxifying, sedative, diuretic and other effects, flavonoids have anti-oxidation, anti-cancer, anti-cancer, and inhibition of lipase. There are also significant effects in other aspects. It is a scavenger for most oxygen free radicals, so it can increase the activity of SOD (superoxide dismutase), reduce the activity of MDA (lipid peroxide malondialdehyde) and OX-LDL (oxidized low-density lipoprotein) generate. It can increase coronary flow, has antagonizing effect on experimental myocardial infarction; has protective effect on acute myocardial ischemia; has significant effect on treating coronary heart disease, angina pectoris, hypertension, etc.; reduces diastolic blood pressure, prevents arrhythmia, cardiovascular Disease and promoting blood circulation and removing blood stasis also play an important role.
大量的科学研究从不同的角度证明了烟草中的烟雾是慢性呼吸系统疾病、冠心病等多种疾病发生的重要危险因素。长期吸烟者一般会有咳嗽、痰多、咽喉痒痛的症状,严重影响人体健康和人类的生活质量。此外,被动吸烟对妇女的健康也造成危害。为了减轻烟草中烟雾对人体的危害,在积极宣传吸烟有害健康和劝导戒烟的同时,也应该积极开发具有舒喉等作用的减害香烟。A large number of scientific studies have proved from different perspectives that tobacco smoke is an important risk factor for the occurrence of chronic respiratory diseases, coronary heart disease and other diseases. Long-term smokers generally have symptoms of cough, phlegm, and sore throat, which seriously affect human health and quality of life. In addition, passive smoking is also harmful to women's health. In order to reduce the harm of smoke in tobacco to the human body, while actively promoting that smoking is harmful to health and persuading smoking cessation, it is also necessary to actively develop harm-reducing cigarettes with functions such as soothing the throat.
喉部是呼吸道的重要组成部分,位于气管和食道的交会处,也是人体发音的重要器官。当吸烟者在吸烟时,最易受到烟气中有害物质影响的就是喉部。烟气中焦油容易截留在吸烟人的体内,在肺中浓缩成一种黏性物质,附着于吸烟者的气管、支气管和肺泡表面,产生物理、化学刺激,影响人体的呼吸;长时间抽烟会降低咽喉部粘膜的防御功能,会出现干咳、喉部刺痛等感觉,或因抽烟导致肝火过旺而给喉部带来不适感;所以抽烟对于人体呼吸道,特别是喉部的危害较大,日久可能会造成喉部病变。The larynx is an important part of the respiratory tract, located at the junction of the trachea and esophagus, and is also an important organ for human pronunciation. When a smoker is smoking, the throat is most susceptible to the harmful substances in the smoke. The tar in the smoke is easily trapped in the smoker's body, condenses into a viscous substance in the lungs, and adheres to the surface of the smoker's trachea, bronchi and alveoli, causing physical and chemical stimulation and affecting the breathing of the human body; smoking for a long time will reduce the The defense function of the mucous membrane of the throat will cause dry cough, throat tingling and other sensations, or the throat will be uncomfortable due to excessive anger caused by smoking; so smoking is more harmful to the human respiratory tract, especially the throat. May cause laryngeal lesions for a long time.
大量相关研究发现呼吸道作为人体直接接触外界气体刺激的器官,是烟草损害的主要承受者。而呼吸道上皮细胞作为呼吸道抵御外界刺激的第一道防线,所受危害尤为严重。既往研究显示香烟刺激可以调节肺泡上皮和支气管上皮尿激酶型纤溶酶原激活物(Urokinase type plasminogen activator,uPA)、尿激酶型纤溶酶原激活物受体(urokinase type plasminogen activator receptor,uPAR)系统表达变化,肺泡上皮细胞uPA和uPAR水平上调更为显著,呈现uPA优势状态,利于蛋白水解。支气管上皮细胞则呈现尿激酶型纤溶酶原激活物抑制剂-1(plasminogen activator inhibitor-1,PAI-1)优势状态,有利于纤维化形成。两种细胞对uPA系统表达状态不同可能可以部分解释COPD患者肺气肿和小气道纤维化这两种不同病理变化的原因。另有文献报道大鼠肺组织切片与香烟烟雾提取物共同孵育,可以增加大鼠肺组织乳酸脱氢酶(lactatec dehydrogenate,LDH)漏出和亚硝酸盐NO2-释放,刺激诱导型一氧化氮合酶(induced nitric oxide synthase,iNOS)活性增加,导致肺损伤。由此可见,长期烟气暴露可引发呼吸道上皮细胞形态及功能损伤,从而影响上下呼吸道的正常生理功能,使吸烟者产生不舒适的感觉,甚至严重影响生存质量(quality of life,QOF)和生命安全。从维护消费者利益出发,走降焦减害之路,是中式卷烟的发展方向。在满足消费者生理、心理需求的前提下,降低其对消费者喉部带来的不利影响,提升喉部舒适性,是烟草行业科研人员亟待解决的问题。A large number of related studies have found that the respiratory tract, as the organ directly exposed to external gas stimulation, is the main recipient of tobacco damage. Respiratory epithelial cells, as the first line of defense against external stimuli, suffer particularly serious damage. Previous studies have shown that cigarette stimulation can regulate alveolar epithelium and bronchial epithelium urokinase type plasminogen activator (uPA), urokinase type plasminogen activator receptor (urokinase type plasminogen activator receptor, uPAR) The expression of the system changed, and the levels of uPA and uPAR in the alveolar epithelial cells were more significantly up-regulated, showing the dominant state of uPA, which was conducive to proteolysis. The bronchial epithelial cells present a dominant state of urokinase-type plasminogen activator inhibitor-1 (plasminogen activator inhibitor-1, PAI-1), which is conducive to the formation of fibrosis. The different expression status of the uPA system in the two cells may partly explain the cause of the two different pathological changes of emphysema and small airway fibrosis in COPD patients. Another literature has reported that co-incubation of rat lung tissue slices with cigarette smoke extracts can increase the leakage of lactate dehydrogenase (lactatec dehydrogenate, LDH) and the release of nitrite NO2- in rat lung tissue, and stimulate inducible nitric oxide synthase. (induced nitric oxide synthase, iNOS) activity increases, leading to lung damage. It can be seen that long-term smoke exposure can cause damage to the morphology and function of respiratory epithelial cells, thereby affecting the normal physiological functions of the upper and lower respiratory tracts, causing smokers to feel uncomfortable, and even seriously affecting the quality of life (QOF) and life. Safety. Starting from safeguarding the interests of consumers, taking the road of reducing tar and harm is the development direction of Chinese cigarettes. On the premise of meeting the physiological and psychological needs of consumers, reducing its adverse effects on the throat of consumers and improving the comfort of the throat are problems that researchers in the tobacco industry need to solve urgently.
喉部舒适性良好是指消费者在品吸卷烟时体验到的烟气平滑细腻、口腔无残留、鼻喉无刺激、回味有甜感等感受。喉部反应在卷烟抽吸过程中主要集中在口腔和呼吸系统部位的感受,体现在降刺、化痰、生津等方面的改善,能够较好地体会到抽吸舒适性。Good throat comfort refers to the smooth and delicate smoke experienced by consumers when smoking cigarettes, no residue in the mouth, no irritation to the nose and throat, and a sweet aftertaste. Laryngeal reaction is mainly concentrated in the mouth and respiratory system during cigarette smoking, which is reflected in the improvement of puncture reduction, phlegm reduction, body fluid production, etc., and can better experience the comfort of smoking.
降刺:刺激性是指烟气对感官的冲击。在感受上分为口腔刺激、鼻腔刺激和喉部刺激三种。刺激性大的,在口腔似有“辣”味,在鼻腔会使人流泪或有流泪感,在喉部会使咽喉紧缩引起咳嗽。Prick reduction: Irritation refers to the impact of smoke on the senses. In terms of feelings, it is divided into three types: oral stimulation, nasal cavity stimulation and throat stimulation. The highly irritating ones seem to have a "spicy" taste in the mouth, cause tears or a sense of tears in the nasal cavity, and constrict the throat and cause coughing in the throat.
烟气的刺激性主要是由卷烟中酸性过大和碱性过大而产生的,同时与烟支的水分、松紧程度等也有关。辣刺是由于碱性物质偏多;呛刺是由于小分子粒状物偏多;尖刺(毛刺)是由于酸性物质偏多。The irritation of smoke is mainly caused by excessive acidity and alkalinity in cigarettes, and is also related to the moisture and tightness of cigarettes. Spicy thorns are due to too much alkaline substances; choking thorns are due to too many small molecule particles; sharp thorns (burrs) are due to too much acidic substances.
黄酮类化合物具有舒张支气管平滑肌的作用,添加在卷烟中,可以减弱烟气的缩管作用,缓解烟气冲击对喉部造成的不适。Flavonoids have the effect of relaxing bronchial smooth muscle. When added to cigarettes, they can weaken the shrinking effect of smoke and relieve the discomfort caused by the impact of smoke on the throat.
化痰:长期吸烟者的人一般会有一定程度的咽炎,其表现是痰多且频。烟气中的有害物质频繁聚集在呼吸道,加速了绒毛纤维的蠕动所致。Resolving phlegm: Long-term smokers generally have a certain degree of pharyngitis, which is manifested by excessive and frequent phlegm. Harmful substances in the smoke frequently accumulate in the respiratory tract, which accelerates the peristalsis of fluff fibers.
黄酮类化合物能够降低烟气生痰物质,势必能够减少该类成分在呼吸系统的堆积。另外,黄酮类化合物能够加速气管绒毛纤维蠕动,使有害物质快速随分泌液排除体外,这就从一定程度上起到了的化痰功效。Flavonoids can reduce phlegm-producing substances in smoke, which is bound to reduce the accumulation of such components in the respiratory system. In addition, flavonoids can accelerate the peristalsis of tracheal villi fibers, so that harmful substances can be quickly excreted from the body with secretions, which to a certain extent has the effect of reducing phlegm.
生津:津为唾液,生津就是使口腔中分泌出唾液。现代医学也认为,唾液中含有多种有助益身体成份,口中生津可以解渴舒顺。Shengjin: Jin is saliva, and Shengjin means to secrete saliva from the mouth. Modern medicine also believes that saliva contains a variety of ingredients that are beneficial to the body, and the production of body fluid in the mouth can quench thirst and comfort.
多种黄酮类化合物具有养阴生津,润肺清火、内热消渴的功效。添加在卷烟中,可刺激口腔味蕾而具有生津效果,烟气更圆润,伴有回甜感,降低干枯感。A variety of flavonoids have the effects of nourishing yin and promoting body fluid, moistening lungs and clearing fire, and quenching thirst due to internal heat. Added in cigarettes, it can stimulate the taste buds in the mouth and have the effect of promoting body fluids. The smoke is more mellow, accompanied by a sense of sweetness, and reduces the sense of dryness.
烟用香料中很多含有黄酮类物质,但是对于专门针对改善喉部舒适性、具有止咳、化痰、平喘功效的香精配方还未见报道,需要作进一步研究。Many tobacco flavors contain flavonoids, but there are no reports on flavor formulas that are specifically aimed at improving throat comfort, cough, phlegm, and asthma, and further research is needed.
发明内容Contents of the invention
针对现有技术的不足,本发明提供一种具有止咳、化痰、平喘功效的含植物黄酮香精的烟用嘴棒制备方法及应用,将植物黄酮香精添加到嘴棒的丝束中,在卷烟抽吸过程中,发挥其优异的抗炎、利喉作用,从而改善卷烟抽吸的喉部舒适性,提高卷烟抽吸品质。Aiming at the deficiencies of the prior art, the present invention provides a preparation method and application of a cigarette mouthpiece containing plant flavonoid essence, which has the effects of relieving cough, reducing phlegm, and relieving asthma. The plant flavonoid essence is added to the tow of the mouthpiece, and the During the smoking process of cigarettes, it exerts its excellent anti-inflammation and throat sharpening effects, thereby improving the throat comfort of cigarette smoking and improving the quality of cigarette smoking.
本发明解决上述技术问题所采用的技术方案是:提供一种含植物黄酮香精的烟用嘴棒制备方法,包括如下步骤:The technical solution adopted by the present invention to solve the above-mentioned technical problems is to provide a method for preparing a cigarette mouthpiece containing plant flavonoid essence, comprising the following steps:
1)按重量百分比称取20%~60%的木犀草素、20%~60%的黄芩苷、10%~30%的山奈酚、10%~30%的柚皮苷,混合后乙醇溶液作为提取溶剂回流提取,过滤得到提取液;1) Weigh 20% to 60% of luteolin, 20% to 60% of baicalin, 10% to 30% of kaempferol and 10% to 30% of naringin by weight percentage, and mix the ethanol solution as The extraction solvent is refluxed for extraction, and filtered to obtain the extract;
2)将提取液均匀喷洒在丝束中;2) Spray the extract evenly in the tow;
3)然后将步骤2)中的丝束干燥;3) then the tow in step 2) is dried;
4)将干燥后的丝束依次用成型纸和嘴棒接装纸包裹,制得含植物黄酮香精的烟用嘴棒。4) Wrapping the dried tow with molding paper and tipping paper successively to prepare a cigarette tip containing plant flavonoid essence.
进一步地,所述乙醇溶液的质量百分浓度为70%~90%。Further, the mass percent concentration of the ethanol solution is 70%-90%.
进一步地,所述步骤1)中回流提取2~4次,每次回流提取2~4小时。Further, in the step 1), the reflux extraction is carried out 2 to 4 times, and each reflux extraction takes 2 to 4 hours.
进一步地,所述步骤3)中的干燥温度为25℃~40℃。Further, the drying temperature in the step 3) is 25°C-40°C.
一种卷烟,包括烟用嘴棒和烟丝,所述烟用嘴棒为上述所述方法制备的含植物黄酮香精的烟用嘴棒。A cigarette, comprising a mouthpiece for tobacco and shredded tobacco, the mouthpiece for tobacco is the mouthpiece for tobacco containing plant flavonoid essence prepared by the method described above.
本发明具有以下优点:The present invention has the following advantages:
1、本发明含植物黄酮香精的烟用嘴棒具有优良的天然气息,给烟支带来舒适的嗅香感觉,烟支抽吸时,这些物质经燃烧裂解出能够增加香气量和香气质的致香成分,进一步提升了卷烟抽吸品质;1. The cigarette mouthpiece containing plant flavonoid essence of the present invention has an excellent natural smell, which brings a comfortable smelling feeling to the cigarette. When the cigarette is smoked, these substances are burned and cracked to produce a fragrance that can increase the amount of aroma and the quality of the aroma. Fragrance components further improve the smoking quality of cigarettes;
2、本发明含植物黄酮香精的烟用嘴棒中活性成分在卷烟中随烟气进入人体口腔,可以直接作用于喉部,起到良好的提高喉部舒适性的作用;2. The active ingredients in the cigarette mouthpiece containing plant flavonoid essence of the present invention enter the oral cavity of the human body along with the smoke in the cigarette, and can directly act on the throat, playing a good role in improving the comfort of the throat;
3、本发明植物黄酮香精原料来源广泛,成本低廉,便于推广应用。3. The plant flavonoid flavor raw materials of the present invention come from a wide range of sources, are low in cost, and are convenient for popularization and application.
具体实施方式Detailed ways
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。In order to make the object, technical solution and advantages of the present invention more clear, the present invention will be further described in detail below in conjunction with the examples. The specific embodiments described here are only used to explain the present invention, not to limit the present invention.
实施例1Example 1
1)将植物黄酮香精按照表1中比例混合,溶于质量百分浓度为70%的乙醇溶液中,回流提取2次,每次提取3小时,过滤、混合得到提取液;1) Mix the plant flavonoid essence according to the ratio in Table 1, dissolve it in an ethanol solution with a mass percentage concentration of 70%, reflux and extract twice, extract for 3 hours each time, filter and mix to obtain an extract;
2)将步骤1)中的提取液均匀喷洒在丝束中;2) evenly spraying the extract in step 1) in the tow;
3)然后将步骤2)中的丝束在25℃下干燥;3) then drying the tow in step 2) at 25°C;
4)将干燥后的丝束依次用成型纸和嘴棒接装纸包裹,制得含植物黄酮香精的烟用嘴棒。4) Wrapping the dried tow with molding paper and tipping paper successively to prepare a cigarette tip containing plant flavonoid essence.
表1Table 1
实施例2Example 2
1)将植物黄酮香精按照表1中比例混合,溶于质量百分浓度为70%的乙醇溶液中,回流提取2次,每次提取4小时,过滤、混合得到提取液;1) Mix the plant flavonoid essence according to the ratio in Table 1, dissolve it in an ethanol solution with a mass percentage concentration of 70%, reflux and extract twice, extract for 4 hours each time, filter and mix to obtain the extract;
2)将步骤1)中的提取液均匀喷洒在丝束中;2) evenly spraying the extract in step 1) in the tow;
3)然后将步骤2)中的丝束在35℃下干燥;3) then drying the tow in step 2) at 35°C;
4)将干燥后的丝束依次用成型纸和嘴棒接装纸包裹,制得含植物黄酮香精的烟用嘴棒。4) Wrapping the dried tow with molding paper and tipping paper successively to prepare a cigarette tip containing plant flavonoid essence.
表2Table 2
实施例3Example 3
1)将植物黄酮香精按照表1中比例混合,溶于质量百分浓度为80%的乙醇溶液中,回流提取4次,每次提取2小时,过滤、混合得到提取液;1) Mix the plant flavonoid essence according to the ratio in Table 1, dissolve it in an ethanol solution with a mass percentage concentration of 80%, reflux extraction 4 times, extract for 2 hours each time, filter and mix to obtain the extract;
2)将步骤1)中的提取液均匀喷洒在丝束中;2) evenly spraying the extract in step 1) in the tow;
3)然后将步骤2)中的丝束在35℃下干燥;3) then drying the tow in step 2) at 35°C;
4)将干燥后的丝束依次用成型纸和嘴棒接装纸包裹,制得含植物黄酮香精的烟用嘴棒。4) Wrapping the dried tow with molding paper and tipping paper successively to prepare a cigarette tip containing plant flavonoid essence.
表3table 3
实施例4Example 4
1)将植物黄酮香精按照表1中比例混合,溶于质量百分浓度为80%的乙醇溶液中,回流提取2次,每次提取4小时,过滤、混合得到提取液;1) Mix the plant flavonoid essence according to the ratio in Table 1, dissolve it in an ethanol solution with a mass percentage concentration of 80%, reflux and extract twice, extract for 4 hours each time, filter and mix to obtain the extract;
2)将步骤1)中的提取液均匀喷洒在丝束中;2) evenly spraying the extract in step 1) in the tow;
3)然后将步骤2)中的丝束在35℃下干燥;3) then drying the tow in step 2) at 35°C;
4)将干燥后的丝束依次用成型纸和嘴棒接装纸包裹,制得含植物黄酮香精的烟用嘴棒。4) Wrapping the dried tow with molding paper and tipping paper successively to prepare a cigarette tip containing plant flavonoid essence.
表4Table 4
实施例5Example 5
1)将植物黄酮香精按照表1中比例混合,溶于质量百分浓度为90%的乙醇溶液中,回流提取2次,每次提取2小时,过滤、混合得到提取液;1) Mix the plant flavonoid essence according to the ratio in Table 1, dissolve it in an ethanol solution with a mass percentage concentration of 90%, reflux and extract twice, extract for 2 hours each time, filter and mix to obtain an extract;
2)将步骤1)中的提取液均匀喷洒在丝束中;2) evenly spraying the extract in step 1) in the tow;
3)然后将步骤2)中的丝束在40℃下干燥;3) then drying the tow in step 2) at 40°C;
4)将干燥后的丝束依次用成型纸和嘴棒接装纸包裹,制得含植物黄酮香精的烟用嘴棒。4) Wrapping the dried tow with molding paper and tipping paper successively to prepare a cigarette tip containing plant flavonoid essence.
表5table 5
实施例6Example 6
1)将植物黄酮香精按照表1中比例混合,溶于质量百分浓度为90%的乙醇溶液中,回流提取4次,每次提取2小时,过滤、混合得到提取液;1) Mix the plant flavonoid essence according to the ratio in Table 1, dissolve it in an ethanol solution with a mass percentage concentration of 90%, reflux extraction 4 times, extract for 2 hours each time, filter and mix to obtain an extract;
2)将步骤1)中的提取液均匀喷洒在丝束中;2) evenly spraying the extract in step 1) in the tow;
3)然后将步骤2)中的丝束在40℃下干燥;3) then drying the tow in step 2) at 40°C;
4)将干燥后的丝束依次用成型纸和嘴棒接装纸包裹,制得含植物黄酮香精的烟用嘴棒。4) Wrapping the dried tow with molding paper and tipping paper successively to prepare a cigarette tip containing plant flavonoid essence.
表6Table 6
针对吸烟所致“咳嗽、痰多、喘息”三大症状,在参照经典的呼吸道镇咳、祛痰、平喘的药效学评价方法的基础上,从多种不同的生物模型中筛选建立适用于天然植物提取物呼吸道保护效果评价的方法,利用小鼠氨水引咳法评价镇咳作用、小鼠酚红排泄法评价祛痰作用、豚鼠离体气管螺旋条法评价平喘作用。Aiming at the three major symptoms of "cough, phlegm, and wheezing" caused by smoking, on the basis of referring to the classic pharmacodynamic evaluation methods of respiratory antitussive, expectorant, and antiasthmatic, a variety of different biological models were screened to establish applicable Based on the method of evaluating the respiratory protection effect of natural plant extracts, the antitussive effect was evaluated by the ammonia water induction method in mice, the expectorant effect was evaluated by the phenol red excretion method in mice, and the antiasthmatic effect was evaluated by the guinea pig isolated trachea spiral strip method.
将以上6个实施例中所制备含植物黄酮香精的烟用嘴棒与烟丝接合做成烟支,对烟支进行烟气成分检测,并进行苯酚降低率比较,具体见下表7The cigarette mouthpieces containing plant flavonoid essence prepared in the above 6 examples are joined with shredded tobacco to make cigarettes, and the smoke components of the cigarettes are tested, and the phenol reduction rate is compared, as shown in the following table 7
表7Table 7
*P<0.05,**P<0.01与同等支数空白卷烟组比较*P<0.05, **P<0.01 compared with blank cigarette group with the same count
对以上6个实施例中实施例中所制备含植物黄酮香精的烟用嘴棒与烟丝接合做成烟支,对烟支进行进行感官评价,结果如表8The mouth sticks for cigarettes containing plant flavonoid essence prepared in the examples of the above 6 examples are joined with shredded tobacco to make cigarettes, and the cigarettes are subjected to sensory evaluation, and the results are shown in Table 8
表8Table 8
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何属于本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到的变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应该以权利要求的保护范围为准。The above is only a specific embodiment of the present invention, but the scope of protection of the present invention is not limited thereto, any changes or substitutions that can be easily imagined by those skilled in the art within the technical scope disclosed in the present invention, All should be covered within the protection scope of the present invention. Therefore, the protection scope of the present invention should be determined by the protection scope of the claims.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510336905.0A CN104905405B (en) | 2015-06-17 | 2015-06-17 | The cigarette of the essence containing plant flavone mouth stick preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510336905.0A CN104905405B (en) | 2015-06-17 | 2015-06-17 | The cigarette of the essence containing plant flavone mouth stick preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104905405A CN104905405A (en) | 2015-09-16 |
CN104905405B true CN104905405B (en) | 2018-05-25 |
Family
ID=54075186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510336905.0A Active CN104905405B (en) | 2015-06-17 | 2015-06-17 | The cigarette of the essence containing plant flavone mouth stick preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104905405B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106617262B (en) * | 2016-12-14 | 2017-11-07 | 湖北中烟工业有限责任公司 | One grows tobacco buccal tablet and preparation method thereof |
CN107400107B (en) * | 2017-07-26 | 2020-06-16 | 云南中烟工业有限责任公司 | Flavonoid compound in rose waste residue and preparation method and application thereof |
CN109266437B (en) * | 2018-09-07 | 2021-10-26 | 云南中烟工业有限责任公司 | Cocoa baking cigarette blasting bead capable of reducing free radicals in smoke and preparation method thereof |
CN109330016A (en) * | 2018-11-14 | 2019-02-15 | 河南中烟工业有限责任公司 | A kind of Exocarpium Citri Grandis medicinal extract, preparation method and the application in cigarette |
CN110693079A (en) * | 2019-09-05 | 2020-01-17 | 云南农业大学 | A kind of pure natural cigarette smoke adsorbent and using method thereof |
CN111990689A (en) * | 2020-08-20 | 2020-11-27 | 广西中烟工业有限责任公司 | Preparation method of chestnut shell pigment cigarette filter stick |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0638727A (en) * | 1991-07-25 | 1994-02-15 | Tsugio Yamamoto | Filter for tobacco |
WO2003053179A1 (en) * | 2001-12-21 | 2003-07-03 | Filtrona Italia S.P.A. | Cigarette filters containing lipophile flavonoids and/or tocopherols and tocotrienols |
CN1488300A (en) * | 2003-08-19 | 2004-04-14 | 广东神农烟科技术有限公司 | Cigarette additive extracted from natural plant, and extracting method and use in cigarette thereof |
CN1781388A (en) * | 2004-12-03 | 2006-06-07 | 李忠 | Wild chrysanthemam flower low harm cigarette capable of reducing cigarette harm |
CN102090712A (en) * | 2010-12-29 | 2011-06-15 | 华宝食用香精香料(上海)有限公司 | Method for preparing coarse extract of peanut shell total flavones and application thereof in cigarettes |
CN104068467A (en) * | 2014-07-01 | 2014-10-01 | 安徽中烟工业有限责任公司 | Electronic cigarette liquid rich in plant flavone |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080053470A1 (en) * | 2006-09-01 | 2008-03-06 | Wu-Ming Tzung | Environmentally friendly cigarette replacement |
-
2015
- 2015-06-17 CN CN201510336905.0A patent/CN104905405B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0638727A (en) * | 1991-07-25 | 1994-02-15 | Tsugio Yamamoto | Filter for tobacco |
WO2003053179A1 (en) * | 2001-12-21 | 2003-07-03 | Filtrona Italia S.P.A. | Cigarette filters containing lipophile flavonoids and/or tocopherols and tocotrienols |
CN1488300A (en) * | 2003-08-19 | 2004-04-14 | 广东神农烟科技术有限公司 | Cigarette additive extracted from natural plant, and extracting method and use in cigarette thereof |
CN1781388A (en) * | 2004-12-03 | 2006-06-07 | 李忠 | Wild chrysanthemam flower low harm cigarette capable of reducing cigarette harm |
CN102090712A (en) * | 2010-12-29 | 2011-06-15 | 华宝食用香精香料(上海)有限公司 | Method for preparing coarse extract of peanut shell total flavones and application thereof in cigarettes |
CN104068467A (en) * | 2014-07-01 | 2014-10-01 | 安徽中烟工业有限责任公司 | Electronic cigarette liquid rich in plant flavone |
Also Published As
Publication number | Publication date |
---|---|
CN104905405A (en) | 2015-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104905405B (en) | The cigarette of the essence containing plant flavone mouth stick preparation method and application | |
CN101974367B (en) | Novel flavor-enhancing and harm-reducing natural spice for tobacco and use thereof | |
CN102952635B (en) | Cigarette spice for enhancing fragrance and relaxing throat and application | |
CN103720040B (en) | A kind of containing Chinese herbal medicine health-care cigarette | |
CN104397871A (en) | Electronic cigarette liquid containing tea extracts and preparation method of electronic cigarette liquid containing tea extracts | |
CN105154227B (en) | Cigarette plant flavone essence cigarette pearl, preparation method and application | |
CN105029689B (en) | Cigarette flavone compound essence cigarette pearl, preparation method and application | |
CN101427844A (en) | Health care cigarette of fig | |
CN105167177B (en) | Cigarette flavones essence cigarette pearl, preparation method and application | |
CN101632489B (en) | Tobacco alcoholizing method capable of reducing tar content and increasing smoking comfort level of cigarettes | |
CN108113049B (en) | Herbal tea flavor liquid essence, microcapsule essence and application of herbal tea flavor liquid essence and microcapsule essence in cigarettes | |
CN104905406B (en) | The cigarette of the essence containing flavone compound mouth stick preparation method and application | |
CN105011369B (en) | The cigarette of the essence containing flavones mouth stick preparation method and application | |
CN103330281A (en) | Agarwood health cigarette | |
CN109998151B (en) | Use of medium chain triglycerides for improving and/or reducing respiratory tract irritation | |
CN113749277B (en) | Atomized liquid with ambergris fragrance and preparation method thereof | |
CN101176570A (en) | Perfume additive for natural tobacco and preparation method thereof | |
CN109043641A (en) | The cigarette and its manufacture craft of eaglewood leaf and linaloe oil mixing | |
CN103549651A (en) | Toxicity attenuation cigarette with anti-cough effect | |
LU100976B1 (en) | New tobacco substitutes | |
CN109757759B (en) | Composition and application thereof in field of cigarettes/cartridges | |
CN103156271B (en) | Shisha paste containing extractive from natural plant Tacca chantrieri Andre and preparation method thereof | |
CN107568785A (en) | A kind of health care cigarette that can be used for smoking cessation and preparation method thereof | |
CN110373264A (en) | A composition containing industrial hemp essential oil for tobacco products | |
CN1391848A (en) | Poisonless cigarette |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |